This extension module explores Endometriosis, examining its core symptoms, comorbidities, and impact to quality of life. This module examines the role of the endocannabinoid system in pain, inflammation, and mood regulation, and evaluates the potential benefits and risks of phytocannabinoids in managing pelvic pain and psychological symptoms.

With a focus on personalized, multimodal care, the module guides the development of evidence-informed treatment plans that integrate medicinal cannabis for patients with refractory symptoms. 

A Case study will be presented to develop and assess clinical reasoning and practice management skills, identify knowledge gaps, and provide a framework for clinical supervision and feedback.

Learning Outcomes

After completing this activity pharmacists should be able to:

1. Identify the common symptoms, co-morbidities and psychosocial impact associated with endometriosis.

2. Identify the clinical relevance of the endocannabinoid system in augmenting pain, inflammation, and mood in the expression of endometriosis.

3. Describe the role of endocannabinoids and potential role for phyto-cannabinoids in endometriosis symptom management.

4. Explain the clinical cautions and relevant risks of medicinal cannabis therapy in endometriosis-related pelvic pain and psychological co-morbidities.

5. Compare utilisation of different dose formats for short and long acting symptom management.

Feedback evaluation forms are provided at the end of each module.